EMedNeXt: An Enhanced Brain Tumor Segmentation Framework for Sub-Saharan Africa using MedNeXt V2 with Deep Supervision

Ahmed Jaheen, Abdelrahman Elsayed, Damir Kim, Daniil Tikhonov, Matheus Scatolin, Mohor Banerjee, Qiankun Ji, Mostafa Salem, Hu Wang, Sarim Hashmi, Mohammad YaqubarXiv 2025 · DOI · arXiv

Introduction

Accurate brain tumor (glioma) segmentation is a critical component of neuro-oncological treatment planning. However, manual segmentation is a labor-intensive process requiring specialized expertise, which is often in short supply in regions like Sub-Saharan Africa (SSA). While deep learning has shown promise in automating this task, most existing models are trained on high-quality datasets from the Global North. These models often fail to generalize to the lower-quality MRI scans—frequently produced by low-field magnets—and the unique patient demographics found in SSA clinical settings.

EMedNeXt addresses these challenges by adapting the MedNeXt V2 architecture specifically for the constraints of low-resource environments. By employing a larger field of view, boundary-aware loss functions, and a "structured freezing" fine-tuning strategy, the framework achieved state-of-the-art results on the BraTS-Lighthouse 2025 challenge.

Methodology

The core of the EMedNeXt framework is MedNeXt V2, which evolves the standard MedNeXt architecture by integrating ConvNeXt-style blocks into a 3D U-Net structure. Several key enhancements were introduced to improve robustness:

  • Architectural Upgrades: The authors unified kernel sizes to a fixed $3 \times 3 \times 3$ and increased the input patch size (Field of View) to $160 \times 160 \times 128$. This larger patch size allows the network to capture more global context, which is essential for orienting the tumor within the brain when image quality is degraded.
  • Deep Supervision: Auxiliary segmentation heads were integrated at multiple decoder levels to facilitate better gradient flow during training.
  • Boundary-Aware Loss: To improve the precision of tumor edges, the researchers combined standard Dice-Focal loss with a 3D Sobel-based boundary term. This forces the model to prioritize the difficult-to-define boundaries of the lesion.
Multi-modal MRI input and corresponding segmentation mask for a coronal slice.

Domain-Adaptive Training Strategy

To overcome the extreme scarcity of annotated data from the SSA region (only 60 training cases), the authors implemented a two-phase training approach:

  1. Pre-training: The model was first trained on the PPTAG (Pre- and Post-Treatment Adult Glioma) dataset, which contains 1,195 high-quality MRI scans. This phase allowed the model to learn a broad distribution of general tumor features.
  2. Structured Fine-tuning: The model was then fine-tuned on the BraTS-SSA dataset. Crucially, the encoder was frozen during this phase. This "structured freezing" strategy prevents overfitting on the small SSA sample while allowing the decoder to adapt to the specific noise and artifacts characteristic of the African clinical data.

Results and Discussion

The EMedNeXt framework demonstrated significant performance gains over the MedNeXt V1 baseline. On the hidden validation set of the BraTS-Lighthouse 2025 challenge, the model achieved an average Lesion-Wise Dice Similarity Coefficient (DSC) of 0.897.

Comparison of different MRI modalities (T1, T1c, T2, FLAIR) and the resulting segmentation (Seg) for slice 120.

The model was particularly effective at segmenting the "Whole Tumor" (WT) class, reaching a Dice score of 0.933. Furthermore, the inclusion of the Sobel operator significantly improved the Normalized Surface Dice (NSD) scores, indicating high accuracy in tracing tumor boundaries. Post-processing steps, including connected-component pruning and hierarchical enforcement (ensuring the Enhancing Tumor is nested within the Tumor Core and Whole Tumor), further refined the final outputs.

Conclusion

EMedNeXt provides a robust solution for brain tumor segmentation in data-scarce and low-resource environments. By combining advanced architectural features with a domain-adaptive training strategy, the framework bridges the performance gap between high-quality research datasets and real-world clinical data from Sub-Saharan Africa. Future work will focus on extending this framework to pediatric populations and exploring newer backbones to further enhance segmentation accuracy.

Summary updated

Abstract

Brain cancer affects millions worldwide, and in nearly every clinical setting, doctors rely on magnetic resonance imaging (MRI) to diagnose and monitor gliomas. However, the current standard for tumor quantification through manual segmentation of multi-parametric MRI is time-consuming, requires expert radiologists, and is often infeasible in under-resourced healthcare systems. This problem is especially pronounced in low-income regions, where MRI scanners are of lower quality and radiology expertise is scarce, leading to incorrect segmentation and quantification. In addition, the number of acquired MRI scans in Africa is typically small. To address these challenges, the BraTS-Lighthouse 2025 Challenge focuses on robust tumor segmentation in sub-Saharan Africa (SSA), where resource constraints and image quality degradation introduce significant shifts. In this study, we present EMedNeXt -- an enhanced brain tumor segmentation framework based on MedNeXt V2 with deep supervision and optimized post-processing pipelines tailored for SSA. EMedNeXt introduces three key contributions: a larger region of interest, an improved nnU-Net v2-based architectural skeleton, and a robust model ensembling system. Evaluated on the hidden validation set, our solution achieved an average LesionWise DSC of 0.897 with an average LesionWise NSD of 0.541 and 0.84 at a tolerance of 0.5 mm and 1.0 mm, respectively.
BibTeX
@misc{jaheen2025emednext,
  author = {Ahmed Jaheen and Abdelrahman Elsayed and Damir Kim and Daniil Tikhonov and Matheus Scatolin and Mohor Banerjee and Qiankun Ji and Mostafa Salem and Hu Wang and Sarim Hashmi and Mohammad Yaqub},
  title = {{EMedNeXt: An Enhanced Brain Tumor Segmentation Framework for Sub-Saharan Africa using MedNeXt V2 with Deep Supervision}},
  year = {2025},
  eprint = {2507.23256},
  archivePrefix = {arXiv},
  url = {https://arxiv.org/abs/2507.23256},
}
Figure